REPARE THERAPEUTICS INC's ticker is RPTX and the CUSIP is 760273102. A total of 65 filers reported holding REPARE THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $153,850 | +14.2% | 12,736 | 0.0% | 0.00% | – |
Q2 2023 | $134,746 | +162.8% | 12,736 | +144.5% | 0.00% | – |
Q1 2023 | $51,266 | -24.8% | 5,210 | +12.5% | 0.00% | – |
Q4 2022 | $68,151 | +19.6% | 4,633 | 0.0% | 0.00% | – |
Q3 2022 | $57,000 | -12.3% | 4,633 | 0.0% | 0.00% | – |
Q2 2022 | $65,000 | +16.1% | 4,633 | +18.1% | 0.00% | – |
Q1 2022 | $56,000 | -32.5% | 3,923 | 0.0% | 0.00% | – |
Q4 2021 | $83,000 | +23.9% | 3,923 | +55.5% | 0.00% | – |
Q3 2021 | $67,000 | +204.5% | 2,523 | +257.4% | 0.00% | – |
Q2 2021 | $22,000 | 0.0% | 706 | 0.0% | 0.00% | – |
Q1 2021 | $22,000 | +37.5% | 706 | +41.2% | 0.00% | – |
Q2 2020 | $16,000 | – | 500 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Versant Venture Management, LLC | 2,646,657 | $28,001,631 | 33.22% |
MPM ASSET MANAGEMENT LLC | 2,242,636 | $23,727,089 | 11.64% |
CHI Advisors LLC | 2,998,734 | $31,726,606 | 9.63% |
MPM BioImpact LLC | 1,639,849 | $17,349,602 | 3.49% |
BVF INC/IL | 8,291,988 | $87,729,233 | 2.44% |
Deep Track Capital, LP | 2,727,606 | $28,858,071 | 1.34% |
Redmile Group, LLC | 2,428,335 | $25,691,784 | 0.99% |
HighVista Strategies LLC | 165,173 | $1,747,530 | 0.80% |
Orbimed Advisors | 3,322,488 | $35,151,923 | 0.64% |
DIFESA CAPITAL MANAGEMENT, LP | 15,416 | $163,101 | 0.43% |